ATR-FTIR spectroscopy and chemometrics: An interesting tool to discriminate and characterize counterfeit medicines.

Counterfeit medicines pose a huge threat to public health worldwide. High amounts of counterfeit pharmaceuticals enter the European market and therefore detection of these products is essential. Attenuated Total Reflection Fourier-Transform infrared spectroscopy (ATR-FTIR) might be useful for the screening of counterfeit medicines since it is easy to use and little sample preparation is required. Furthermore, this approach might be helpful to customs to obtain a first evaluation of suspected samples. This study proposes a combination of ATR-FTIR and chemometrics to discriminate and classify counterfeit medicines. A sample set, containing 209 samples in total, was analyzed using ATR-FTIR and the obtained spectra were used as fingerprints in the chemometric data-analysis which included Principal Component Analysis (PCA), k-Nearest Neighbours (k-NN), Classification and Regression Trees (CART) and Soft Independent Modelling of Class Analogy (SIMCA). First it was verified whether the mentioned techniques are capable to distinguish samples containing different active pharmaceutical ingredients (APIs). PCA showed a clear tendency of discrimination based on the API present; k-NN, CART and SIMCA were capable to create suitable prediction models based on the presence of different APIs. However k-NN performs the least while SIMCA performs the best. Secondly, it was tested whether these three models could be expanded to discriminate between genuine and counterfeit samples as well. k-NN was not able to make the desired discrimination and therefore it was not useful. CART performed better but also this model was less suited. SIMCA, on the other hand, resulted in a model with a 100% correct discrimination between genuine and counterfeit drugs. This study shows that chemometric analysis of ATR-FTIR fingerprints is a valuable tool to discriminate genuine from counterfeit samples and to classify counterfeit medicines.

[1]  Zdzisław Chilmonczyk,et al.  1H, 13C, 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage forms. , 2005, Journal of pharmaceutical and biomedical analysis.

[2]  T. De Beer,et al.  Comparison and combination of spectroscopic techniques for the detection of counterfeit medicines. , 2010, Journal of pharmaceutical and biomedical analysis.

[3]  Patrícia Valderrama,et al.  Non-destructive detection of adulterated tablets of glibenclamide using NIR and solid-phase fluorescence spectroscopy and chemometric methods. , 2012, Journal of pharmaceutical and biomedical analysis.

[4]  D L Massart,et al.  Classification of drugs in absorption classes using the classification and regression trees (CART) methodology. , 2005, Journal of pharmaceutical and biomedical analysis.

[5]  B. Venhuis,et al.  The identification of a nitrosated prodrug of the PDE-5 inhibitor aildenafil in a dietary supplement: a Viagra with a pop. , 2011, Journal of pharmaceutical and biomedical analysis.

[6]  Annelien Deneckere,et al.  Detection of counterfeit Viagra with Raman spectroscopy. , 2008, Journal of pharmaceutical and biomedical analysis.

[7]  Véronique Gilard,et al.  Analysis of illegally manufactured formulations of tadalafil (Cialis) by 1H NMR, 2D DOSY 1H NMR and Raman spectroscopy. , 2008, Journal of pharmaceutical and biomedical analysis.

[8]  Facundo M Fernandez,et al.  Detecting counterfeit antimalarial tablets by near-infrared spectroscopy. , 2008, Journal of pharmaceutical and biomedical analysis.

[9]  M. Johansson,et al.  Screening of counterfeit corticosteroid in creams and ointments by NMR spectroscopy. , 2012, Journal of pharmaceutical and biomedical analysis.

[10]  Yvan Vander Heyden,et al.  Classification Tree Models for the Prediction of Blood-Brain Barrier Passage of Drugs , 2006, J. Chem. Inf. Model..

[11]  E. Deconinck,et al.  Evaluation of the residual solvent content of counterfeit tablets and capsules. , 2013, Journal of pharmaceutical and biomedical analysis.

[12]  M. Daszykowski,et al.  Impurity fingerprints for the identification of counterfeit medicines--a feasibility study. , 2011, Analytica chimica acta.

[13]  A. B. Champagne,et al.  Rapid screening test for adulteration in raw materials of dietary supplements , 2011 .

[14]  Pierre Margot,et al.  Profiling of counterfeit medicines by vibrational spectroscopy. , 2011, Forensic science international.

[15]  E. Deconinck,et al.  Chemometrics and chromatographic fingerprints to discriminate and classify counterfeit medicines containing PDE-5 inhibitors. , 2012, Talanta.

[16]  Rafael S Ortiz,et al.  Counterfeit Cialis and Viagra fingerprinting by ATR-FTIR spectroscopy with chemometry: can the same pharmaceutical powder mixture be used to falsify two medicines? , 2013, Forensic science international.

[17]  B. Walczak,et al.  Discrimination of biofilm samples using pattern recognition techniques , 2007, Analytical and bioanalytical chemistry.

[18]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[19]  D de Kaste,et al.  Structure elucidation of a novel synthetic thiono analogue of sildenafil detected in an alleged herbal aphrodisiac. , 2008, Journal of pharmaceutical and biomedical analysis.

[20]  R Hoogerbrugge,et al.  Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy. , 2006, Journal of pharmaceutical and biomedical analysis.

[21]  E. Deconinck,et al.  A validated GC-MS method for the determination and quantification of residual solvents in counterfeit tablets and capsules. , 2012, Journal of pharmaceutical and biomedical analysis.

[22]  Eric R. Ziegel,et al.  Handbook of Chemometrics and Qualimetrics, Part B , 2000, Technometrics.

[23]  I. Storme-Paris,et al.  Challenging near infrared spectroscopy discriminating ability for counterfeit pharmaceuticals detection. , 2010, Analytica chimica acta.

[24]  J. Maurin,et al.  The usefulness of simple X-ray powder diffraction analysis for counterfeit control--the Viagra example. , 2007, Journal of pharmaceutical and biomedical analysis.

[25]  Johanna Smeyers-Verbeke,et al.  Handbook of Chemometrics and Qualimetrics: Part A , 1997 .

[26]  G. Jackson,et al.  Assessing the problem of counterfeit medications in the United Kingdom , 2012, International journal of clinical practice.